ROCKET PHARMACEUTICALS, INC. Balance Sheet
RCKT|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
ROCKET PHARMACEUTICALS, INC. had $330M in total assets and $463M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77.6M | $163.6M | $55.9M | $140.5M | $232.7M | $297.1M | $185.4M | $111.4M |
| Current Assets | $192.7M | $378.2M | $378.2M | $364.1M | $392.1M | $487.3M | $307.8M | $209.1M |
| PP&E (Net) | $28.2M | $36.8M | $39.2M | $29.0M | $22.3M | $19.2M | $29.3M | $2.0M |
| Goodwill | $39.2M | $39.2M | $39.2M | $30.8M | $30.8M | $30.8M | $30.8M | $30.8M |
| Total Assets | $330.4M | $527.7M | $566.3M | $551.8M | $497.0M | $590.8M | $372.1M | $251.3M |
| Current Liabilities | $30.2M | $40.7M | $48.5M | $39.2M | $22.2M | $32.6M | $18.3M | $15.4M |
| Shareholders' Equity | $463.2M | $492.6M | $454.7M | $503.5M | $307.3M | $194.0M | $15.5M | $15.5M |